The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours

Neuroendocrine tumours have a particular tendency to express functional receptors and/or uptake mechanisms. Radionuclides, such as 123I-MIBG, which is taken up by a specific uptake mechanism, and 111in-pentetreotide, which binds to somatostatin receptors, present an imaging modality based on these p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2001, Vol.12 (suppl-2), p.S47-S50
Hauptverfasser:	Kaltsas, G.A., Mukherjee, J.J., Grossman, A.B.
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine - pharmacokinetics Antineoplastic agents Biological and medical sciences Chemotherapy Humans Iodine Radioisotopes Medical sciences Multiple tumors. Solid tumors. Tumors in childhood (general aspects) neuroendocrine Neuroendocrine Tumors - diagnostic imaging Neuroendocrine Tumors - radiotherapy Octreotide - analogs & derivatives Octreotide - pharmacokinetics Pharmacology. Drug treatments Radioisotopes - therapeutic use Radionuclide Imaging radionuclides Radiopharmaceuticals - pharmacokinetics Somatostatin - analogs & derivatives Somatostatin - pharmacokinetics Tumors tumours Yttrium Radioisotopes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!